Cargando…

Complex cutaneous infection by Leishmania mexicana treated with miltefosine

Detalles Bibliográficos
Autores principales:	Sadowsky, Rachel L., Emerson, Catherine M., Reid, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522873/ https://www.ncbi.nlm.nih.gov/pubmed/36186411 http://dx.doi.org/10.1016/j.jdcr.2022.08.036

Ejemplares similares

SUCCESSFUL TREATMENT OF MULTIFOCAL CUTANEOUS LEISHMANIASIS WITH MILTEFOSINE
por: Madke, Bhushan, et al.
Publicado: (2011)

Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol
por: Gonçalves, Gustavo, et al.
Publicado: (2021)

Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine
por: Dorlo, Thomas P. C., et al.
Publicado: (2011)

Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition
por: Bulté, Dimitri, et al.
Publicado: (2021)

Resolution of tongue lesions caused by Leishmania infantum in a dog treated with the association miltefosine-allopurinol
por: Foglia Manzillo, Valentina, et al.
Publicado: (2009)

Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients
por: OLLECH, Ayelet, et al.
Publicado: (2020)

Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
por: Machado, Paulo R., et al.
Publicado: (2010)

Leishmania Resistance to Miltefosine Associated with Genetic Marker
por: Cojean, Sandrine, et al.
Publicado: (2012)

Internalization of Leishmania mexicana Complex Amastigotes via the Fc Receptor Is Required to Sustain Infection in Murine Cutaneous Leishmaniasis
por: Kima, Peter E., et al.
Publicado: (2000)

Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
por: dos Santos Nogueira, Fabio, et al.
Publicado: (2019)

Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
por: Vincent, Isabel M., et al.
Publicado: (2015)

Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major
por: Turner, Kimbra G., et al.
Publicado: (2015)

Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana
por: Fuentes-Nava, Gabriela, et al.
Publicado: (2021)

In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis
por: Coelho, Adriano C., et al.
Publicado: (2014)

Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis
por: Castro, María del Mar, et al.
Publicado: (2017)

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2023)

Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches
por: Rebello, Karina M., et al.
Publicado: (2019)

Relapse of visceral leishmaniasis in an HIV-infected patient successfully treated with a combination of miltefosine and amphotericin B
por: McQuarrie, Shauna, et al.
Publicado: (2015)

Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages
por: Voak, Andrew A, et al.
Publicado: (2018)

New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates
por: Bhattacharya, Arijit, et al.
Publicado: (2018)

Oral miltefosine for refractory Acanthamoeba keratitis
por: Hirabayashi, Kristin E., et al.
Publicado: (2019)

Leishmania (Leishmania) mexicana Infection in Wild Rodents from an Emergent Focus of Cutaneous Leishmaniasis in Yucatan, Mexico
por: Sosa-Bibiano, Erika I., et al.
Publicado: (2022)

Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine
por: Armitage, Emily G., et al.
Publicado: (2018)

Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
por: Van Bockstal, Lieselotte, et al.
Publicado: (2020)

Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection
por: Hendrickx, Sarah, et al.
Publicado: (2020)

In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up
por: Coelho, Adriano C., et al.
Publicado: (2016)

Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility
por: Santi, Ana Maria Murta, et al.
Publicado: (2021)

Draft Genome Sequences of Leishmania (Leishmania) amazonensis, Leishmania (Leishmania) mexicana, and Leishmania (Leishmania) aethiopica, Potential Etiological Agents of Diffuse Cutaneous Leishmaniasis
por: Batra, Dhwani, et al.
Publicado: (2019)

Relapse after Treatment with Miltefosine for Visceral Leishmaniasis Is Associated with Increased Infectivity of the Infecting Leishmania donovani Strain
por: Rai, Keshav, et al.
Publicado: (2013)

Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging
por: Reimão, Juliana Q., et al.
Publicado: (2015)

3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine
por: Carnielli, Juliana B.T., et al.
Publicado: (2022)

Post-kala-azar Dermal Leishmaniasis Developing in Miltefosine-Treated Visceral Leishmaniasis
por: Koley, Sankha, et al.
Publicado: (2013)

A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
por: Carnielli, Juliana B.T., et al.
Publicado: (2018)

Miltefosine-Induced Apoptotic Cell Death on Leishmania major and L. tropica Strains
por: Khademvatan, Shahram, et al.
Publicado: (2011)

In-Depth Quantitative Proteomics Characterization of In Vitro Selected Miltefosine Resistance in Leishmania infantum
por: Saboia-Vahia, Leonardo, et al.
Publicado: (2022)

Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
por: Bastola, Anup, et al.
Publicado: (2019)

Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis
por: Melcon-Fernandez, Estela, et al.
Publicado: (2023)

In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization
por: Shaw, C. D., et al.
Publicado: (2016)

Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature
por: Mosimann, Vincent, et al.
Publicado: (2016)

Leishmania Promastigotes Lack Phosphatidylserine but Bind Annexin V upon Permeabilization or Miltefosine Treatment
por: Weingärtner, Adrien, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v4m1v9ga2gd86k2rq5hi7etnl4